Quarterly report · Q2
4889.TEDINET S100PHKX
Period2022-04-01 → 2022-09-30
Filed2022-11-10
StandardJapan GAAP
ConsolidatedNo
Data checks10 of 10 passed
Key figures · 43
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Operating income | −¥153m | 2022-04-01 → 2022-09-30 | Standalone | Operating income |
| Operating income | −¥91m | 2021-04-01 → 2021-09-30 | Standalone | Operating income |
| Ordinary income | −¥153m | 2022-04-01 → 2022-09-30 | Standalone | Ordinary income |
| Ordinary income | −¥242m | 2021-04-01 → 2022-03-31 | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | −¥119m | 2021-04-01 → 2021-09-30 | Standalone | Ordinary income |
| Profit before tax | −¥153m | 2022-04-01 → 2022-09-30 | Standalone | Income before income taxes |
| Profit before tax | −¥119m | 2021-04-01 → 2021-09-30 | Standalone | Income before income taxes |
| Net income | −¥154m | 2022-04-01 → 2022-09-30 | Standalone | Profit loss |
| Net income | −¥254m | 2021-04-01 → 2022-03-31 | Standalone | Net income loss (5-year summary) |
| Net income | −¥119m | 2021-04-01 → 2021-09-30 | Standalone | Profit loss |
| Total assets | ¥2.4bn | at 2022-09-30 | Standalone | Assets |
| Total assets | ¥2.4bn | at 2022-03-31 | Standalone | Assets |
| Total assets | ¥2.7bn | at 2021-09-30 | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥355m | at 2022-09-30 | Standalone | Liabilities |
| Total liabilities | ¥237m | at 2022-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥2.0bn | at 2022-09-30 | Standalone | Net assets |
| Net assets / equity | ¥2.2bn | at 2022-03-31 | Standalone | Net assets |
| Net assets / equity | ¥2.1bn | at 2021-09-30 | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥2.3bn | at 2022-09-30 | Standalone | Cash and deposits |
| Cash and deposits | ¥2.4bn | at 2022-03-31 | Standalone | Cash and deposits |
| Cash & equivalents | ¥2.0bn | at 2022-09-30 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥2.0bn | at 2022-03-31 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥2.3bn | at 2021-09-30 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥645m | at 2021-03-31d | Standalone | Cash and cash equivalents |
| Operating cash flow | −¥140m | 2022-04-01 → 2022-09-30 | Standalone | Net cash provided by used in operating activities |
| Operating cash flow | −¥230m | 2021-04-01 → 2022-03-31 | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥26m | 2021-04-01 → 2021-09-30 | Standalone | Net cash provided by used in operating activities |
| Investing cash flow | −¥320,000 | 2022-04-01 → 2022-09-30 | Standalone | Net cash provided by used in investment activities |
| Investing cash flow | −¥296,000 | 2021-04-01 → 2022-03-31 | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | ¥98m | 2022-04-01 → 2022-09-30 | Standalone | Net cash provided by used in financing activities |
| Financing cash flow | ¥1.6bn | 2021-04-01 → 2022-03-31 | Standalone | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥1.7bn | 2021-04-01 → 2021-09-30 | Standalone | Net cash provided by used in financing activities |
| EPS (basic) | ¥-12.1 | 2022-04-01 → 2022-09-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-7.1 | 2022-07-01 → 2022-09-30d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-22.33 | 2021-04-01 → 2022-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-11.78 | 2021-04-01 → 2021-09-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-8.44 | 2021-07-01 → 2021-09-30d | Standalone | Basic earnings loss per share (5-year summary) |
| Equity ratio | 85.2% | at 2022-09-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 90.3% | at 2022-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 76.3% | at 2021-09-30 | Standalone | Equity to asset ratio (5-year summary) |
| Shares issued | 12,711,700 | at 2022-09-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 12,711,700 | at 2022-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 12,269,000 | at 2021-09-30 | Standalone | Total number of issued shares (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
All source rows · 337
| Item | Context | Value | Unit |
|---|---|---|---|
| Filer name in english | FilingDateInstant | Renascience Inc. | |
| Fund name in japanese | FilingDateInstant | － | |
| Fund name in english | FilingDateInstant | － | |
| Cabinet office ordinance | FilingDateInstant | Original text (Japanese)企業内容等の開示に関する内閣府令 | |
| Document type | FilingDateInstant | Original text (Japanese)第四号の三様式 | |
| Accounting standards | FilingDateInstant | Japan GAAP | |
| Whether consolidated financial statements are prepared | FilingDateInstant | false | |
| Industry code when consolidated financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | － | |
| Industry code when financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | cte | |
| Current fiscal year start date | FilingDateInstant | 2022-04-01 | |
| Current period end date | FilingDateInstant | 2022-09-30 | |
| Type of current period | FilingDateInstant | Q2 | |
| Current fiscal year end date | FilingDateInstant | 2023-03-31 | |
| Previous fiscal year start date | FilingDateInstant | 2021-04-01 | |
| Comparative period end date | FilingDateInstant | 2021-09-30 | |
| Previous fiscal year end date | FilingDateInstant | 2022-03-31 | |
| Next fiscal year start date | FilingDateInstant | － | |
| End date of quarterly or semi annual period of next fiscal year | FilingDateInstant | － | |
| Amendment flag | FilingDateInstant | false | |
| Identification of document subject to amendment | FilingDateInstant | － | |
| Report amendment flag | FilingDateInstant | false | |
| Xbrl amendment flag | FilingDateInstant | false | |
| Business results of reporting company (text) | FilingDateInstant | Text · Plus | |
| Description of business (text) | FilingDateInstant | Text · Plus | |
| Business risks (text) | FilingDateInstant | Text · Plus | |
| Management analysis of financial position operating results and cash flows (text) | FilingDateInstant | Text · Plus | |
| Critical contracts for operation (text) | FilingDateInstant | Text · Plus | |
| Total number of shares (text) | FilingDateInstant | Text · Plus | |
| Issued shares total number of shares etc (text) | FilingDateInstant | Text · Plus | |
| Class issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)普通株式 | |
| Name of financial instruments exchange on which securities are listed or authorized financial instruments business association to which securities are registered | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)東京証券取引所グロース市場 | |
| Description issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | Text · Plus | |
| Details of employee share option program (text) | FilingDateInstant | Text · Plus | |
| Other information on share acquisition rights (text) | FilingDateInstant | Text · Plus | |
| Exercises etc of moving strike convertible bonds etc (text) | FilingDateInstant | Text · Plus | |
| Changes in number of issued shares stated capital etc (text) | FilingDateInstant | Text · Plus | |
| Major shareholders (text) | FilingDateInstant | Text · Plus | |
| Name major shareholders | CurrentQuarterInstant_No1MajorShareholdersMember | Original text (Japanese)特定有価証券信託受託者 株式会社ＳＭＢＣ信託銀行 | |
| Address major shareholders | CurrentQuarterInstant_No1MajorShareholdersMember | Original text (Japanese)東京都千代田区丸の内一丁目３番２号 | |
| Name major shareholders | CurrentQuarterInstant_No2MajorShareholdersMember | Original text (Japanese)大和日台バイオベンチャー 投資事業有限責任組合 | |
| Address major shareholders | CurrentQuarterInstant_No2MajorShareholdersMember | Original text (Japanese)東京都千代田区丸の内一丁目９番１号 | |
| Name major shareholders | CurrentQuarterInstant_No3MajorShareholdersMember | Original text (Japanese)宮田敏男 | |
| Address major shareholders | CurrentQuarterInstant_No3MajorShareholdersMember | Original text (Japanese)宮城県仙台市青葉区 | |
| Name major shareholders | CurrentQuarterInstant_No4MajorShareholdersMember | Original text (Japanese)ＳＭＢＣ社会課題解決投資事業有限責任組合 | |
| Address major shareholders | CurrentQuarterInstant_No4MajorShareholdersMember | Original text (Japanese)東京都中央区八重洲一丁目３番４号 | |
| Name major shareholders | CurrentQuarterInstant_No5MajorShareholdersMember | Original text (Japanese)ＢＮＹ ＧＣＭ ＣＬＩＥＮＴ ＡＣＣＯＵＮＴ ＪＰＲＤ ＡＣ ＩＳＧ（ＦＥ－ＡＣ）（常任代理人 株式会社三菱ＵＦＪ銀行） | |
| Address major shareholders | CurrentQuarterInstant_No5MajorShareholdersMember | Text · Plus | |
| Name major shareholders | CurrentQuarterInstant_No6MajorShareholdersMember | Original text (Japanese)ＪＰモルガン証券株式会社 | |
| Address major shareholders | CurrentQuarterInstant_No6MajorShareholdersMember | Original text (Japanese)東京都千代田区丸の内二丁目７番３号 | |
| Name major shareholders | CurrentQuarterInstant_No7MajorShareholdersMember | Original text (Japanese)７７ニュービジネス投資事業 有限責任組合 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 10 of 10 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |